Found on pharmacist.com
Group by:
Title Date Type
Moderna plans to begin testing its coronavirus vaccine in children
New York Times (12/03/20) Grady, Denise
The drugmaker Moderna said on Wednesday that it would soon begin testing its coronavirus vaccine in children aged 12 years through 17 years. The study is to include 3,000 children, with one-half receiving two shots of vaccine 4 weeks apart, and one-half getting placebo shots of salt water. The…
Dec 02, 2020 Publication Pharmacy Today Daily Edition
COVID-19 likely in U.S. in mid-December 2019, CDC scientists report
Wall Street Journal (12/01/20) McKay, Betsy
The new coronavirus infected people in the United States in mid-December 2019, a few weeks before it was officially identified in China and about a month earlier than public health authorities found the first U.S. case, according to a new government study. The findings significantly strengthen…
Dec 02, 2020 Publication Pharmacy Today Daily Edition
Baxter Healthcare recalls Baxter SIGMA Spectrum infusion pumps with Master Drug Library and Spectrum IQ Infusion Systems with Dose IQ Safety Software
FDA Recalls, Market Withdrawals, & Safety Alerts (12/01/20)
Baxter Healthcare announced a recall of the Baxter Healthcare Sigma Spectrum Infusion Pumps with Master Drug Library (versions 6 and 8) and the Baxter Spectrum IQ Infusion Systems with Dose IQ Safety Software (version 9) due to unplanned shutdown issues. According to Baxter, improper cleaning of…
Dec 02, 2020 Publication Pharmacy Today Daily Edition
A cluster-randomized trial of hydroxychloroquine for prevention of COVID-19
New England Journal of Medicine (11/24/20) Mitjà, Oriol; Corbacho-Monné, Marc; Ubals, Maria; et al.
Members of Spain's BCN-PEP-CoV2 Research Group conducted a study to examine the use of hydroxychloroquine as a postexposure therapy to prevent COVID-19. They conducted an open-label, cluster-randomized trial involving asymptomatic contacts of patients with polymerase-chain-reaction (PCR)–…
Dec 02, 2020 Publication Pharmacy Today Daily Edition
For COVID long-haulers, a little-known diagnosis offers possible treatments--and new challenges
Wall Street Journal (11/30/20) Reddy, Sumathi
Physicians are diagnosing some long-term COVID-19 patients with postural orthostatic tachycardia syndrome (POTS), a disorder of the autonomic nervous system that can have a variety of causes. A frequent trigger for POTS is an infection, such as by a virus. Experts say protocols and treatments for…
Dec 02, 2020 Publication Pharmacy Today Daily Edition
Drugmaker Merck divests stake in vaccine-maker Moderna
CNBC.com (12/02/20)
Drugmaker Merck said on Wednesday it has sold its equity investment in Moderna, after benefiting from a surge in the stock price of the vaccine developer this year. Merck did not disclose the details of the sale proceeds, but said it expects to record a small gain from the sale in the fourth…
Dec 02, 2020 Publication Pharmacy Today Daily Edition
AstraZeneca sells former blockbuster cholesterol drug for $320 million
Reuters (12/01/20) B, Aakash
AstraZeneca said on Tuesday it would sell rights to its erstwhile blockbuster cholesterol drug, rosuvastatin calcium (Crestor), to German pharmaceutical company Gruenenthal for an upfront payment of $320 million. AstraZeneca, which is among the front-runners in the race to develop a vaccine for the…
Dec 02, 2020 Publication Pharmacy Today Daily Edition
STAT-Harris Poll: Most Americans won't get a COVID-19 vaccine unless it cuts risk by one-half
STAT News (11/10/20) Silverman, Ed
A new survey from STAT and The Harris Poll found that 6 in 10 Americans said they are somewhat or very likely to get a coronavirus vaccine if doing so would reduce the risk of contracting COVID-19 by roughly one-half. Moreover, the poll suggests that more Americans are likely to get a vaccine,…
Dec 02, 2020 Publication Pharmacy Today Daily Edition
Pushed to rush, FDA head says feds will get vaccine 'right'
Associated Press (12/01/20) Lemire, Jonathan; Colvin, Jill; Perrone, Matthew; et al.
Despite increasing pressure from President Donald Trump to speed up the process to authorize COVID-19 vaccines, FDA Commissioner Stephen Hahn, MD, said the agency would take the time needed to "get this right." Hahn said the FDA will thoroughly review each vaccine before making it available to the…
Dec 02, 2020 Publication Pharmacy Today Daily Edition
Trump administration silent after Canada blocks U.S. plan to import some prescription drugs
Toronto Globe & Mail (12/01/20)
The Trump administration has so far had no comment on Canada's decision to block U.S. imports of certain prescription drugs from north of the border. Health Minister Patty Hajdu on November 28 prohibited bulk drug exports if they pose a risk of creating or worsening drug shortages in the Canadian…
Dec 02, 2020 Publication Pharmacy Today Daily Edition